Strategic Insights Series Now Available from Decision Resources
Series Launches With Strategic Reports Evaluating Market Access Opportunities for Oncology Agents and the Role of HONDAs in Rising Healthcare Costs
BURLINGTON, Mass., Sept. 16, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announces the availability of Strategic Insights. This new series evaluates the most critical industry trends to inform biopharmaceutical corporate, commercial, development and marketing strategies to achieve future success. Reports integrate proprietary data, primary and secondary market research, modeling and key opinion leader insight from Decision Resources Group companies to identify the game-changing trends in today's market, assess their impact and deliver actionable recommendations.
The series launches with the publication of its first two reports, Market Access Levers and Barriers: Optimizing the Opportunity for Key Oncology Agents and How Far Are HONDAs Driving Healthcare Costs? Future reports will evaluate a range of industry hot topics from drug development and commercialization, biosimilars and market access to corporate activity, growth markets and digital media. Reports are tailored for the busy biopharmaceutical professional, offering robust yet concise insights.
"Our Strategic Insights series leverages the expertise and experience of Decision Resources Group analysts to provide clients with the information they need to anticipate and adapt to an evolving biopharma landscape," said Decision Resources Group Senior Vice President, Research Kate Hohenberg. "We offer easily digested, visually appealing analysis targeted to the busy executive who needs to quickly understand how industry trends affect business now and in the future."
About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Decision Resources Group
SOURCE Decision Resources Group
More by this Source
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
Apr 15, 2014, 13:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.